<DOC>
	<DOCNO>NCT03098615</DOCNO>
	<brief_summary>This study examine Jublia affect dermatophytomas , difficult treat therapeutic option .</brief_summary>
	<brief_title>Study Evaluating Effect Jublia Dermatophytomas</brief_title>
	<detailed_description>Dermatophytomas know resistant even long course systemic antifungal , therefore exclude topical systemic clinical trial onychomycosis , include Efinaconazole solution . Efinaconazole ( Jublia ) 10 % solution FDA approve topical medication indicate treatment DLSO , utility medication likely exceeds publish result . Efinaconazole solution 's novel ability penetrate subungal space likely account improve treatment result see DLSO treat Jublia . We investigate utility topical efinaconazole solution treatment dermatophytomas .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Efinaconazole</mesh_term>
	<criteria>Has inform consent sign patient 's question answer . Age &gt; = 18 Patient willing able participate full duration study No onychomycosis Greater 4 week prior major surgery indication Willing abstain : The application topical medication cosmetic product toenail Professional pedicure duration study . Females childbearing potential must : Have use adequate contraception ( abstinence , IUD , birth control pills spermicidal gel diaphragm condom ) since last menses Agree continue use adequate mean contraception ( abstinence , IUD , birth control pills spermicidal gel diaphragm condom ) duration study participation Females consider childbearing potential least 1 year postmenopausal tubal ligation , bilateral oophorectomy hysterectomy . Active onychomycosis toenail fingernails Any follow 4 week ( indicate ) prior randomization : Major surgery indication Any personal history : Invasive cancer diagnose treat within past 5 year . Participants remission 5 year require treatment past 5 year may eligible principal investigator believe little risk recurrence . Concurrent use follow medication treatment Other topical antifungal concomitant infection Females pregnant lactating . Should woman become pregnant suspect pregnant participate study notify study physician immediately . Uncontrolled concurrent illness include ongoing active infection , psychiatric illness/social situation would limit compliance study requirement underlie serious medical condition , investigator 's opinion , might preclude study participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>